Best fundraising quarter of the year for UK biotech

But government called on to maintain support for life science sector

The UK’s biotech sector has enjoyed its best funding quarter of 2022 so far as it raised £579 million, according to new data, with £247m in venture capital and £332m in public follow-on financing.

Released on 21 October, the data from trade body the Bioindustry Association (BIA) and analytics company Clarivate* revealed that investment in the sector had risen in the summer compared to the rest of the year, as £450m was raised in spring and £481m at the beginning of the year.